Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-12-18
2000-06-27
Prouty, Rebecca E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 530350, 530324, 435 691, 435183, A61K 3800
Patent
active
060807237
ABSTRACT:
The invention provides a human actVA-ORF4-like protein (A-ORFP) and polynucleotides which identify and encode A-ORFP. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of A-ORFP.
REFERENCES:
Caballero et al. (1991) Organisation and functions of the actVA region of the actinorhodin biosynthetic gene cluster of Streptomyces coelicolor. Mol. Gen. Genet. 230:41-412.
Database EMBL on STN. Caballero et al. (1995) Accession No. S18542. Hypothetical protein 4--Streptomyces coelicolor.
Barton (1996) "Protein Sequence Alignment and Database Scanning" In, Protein Structure Prediction, A Practical Approach, IRL Press at Oxford University Press, Oxford, UK. pp. 31-63.
George et al. (1988) "Current Methods in Sequence Comparison and Analysis" In, Macromolecular Sequencing and Synthesis, Selected Methods and Applications. D.H. Schlesinger (Ed) Alan R. Liss, Inc. New York, NY, pp. 127-149.
Corley Neil C.
Lal Preeti
Shah Purvi
Tang Tom
Hamlet-Cox Diana
Incyte Pharmaceuticals Inc.
Longton Enrique D.
Prouty Rebecca E.
LandOfFree
Human actVA-ORF4-like protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human actVA-ORF4-like protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human actVA-ORF4-like protein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1784835